GSK PLC Board and Committee Changes (8920J)
16 December 2022 - 02:30AM
UK Regulatory
TIDMGSK
RNS Number : 8920J
GSK PLC
15 December 2022
GSK plc
Board Committee Changes
GSK plc today announces the following change to its Board
Committee membership:
Having completed over five years as Science Committee Chair, Dr
Jesse Goodman will end his rotation and Dr Hal Dietz will succeed
him as Committee Chair with effect from 1 January 2023.
V A Whyte
Company Secretary
15 December 2022
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOAFLFFEFDLELIF
(END) Dow Jones Newswires
December 15, 2022 10:30 ET (15:30 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Feb 2024 to Mar 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2023 to Mar 2024